Third-line treatment for metastatic renal cell carcinoma
Metastatic renal cell carcinoma refers to cancer of the kidneys that has spread to other sites in the body.
Some cancer cells produces many proteins known as vascular endothelial growth factors (VEGFs) that stimulate the growth of blood vessels that cancers need to support their growth. Anti-VEGF therapy inhibits these proteins, thus preventing the growth of cancer cells.
Anti-VEGF therapy that was not previously used is recommended for third-line treatment.
Best supportive care, medical care that focuses on relieving the symptoms caused by serious illnesses, is an option.